Allarity Therapeutics, Inc. Common Stock

ALLRNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
1.61 USD
↘ 0.09 (5.29%)AT CLOSE (11:59 AM EDT)
1.60
↘ 0.01 (0.68%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
1.60
↘ 0.01 (0.68%)
🔴Market: CLOSED
Open?$1.71
High?$1.72
Low?$1.56
Prev. Close?$1.70
Volume?157.0K
Avg. Volume?243.3K
VWAP?$1.63
Rel. Volume?0.65x
Bid / Ask
Bid?$1.36 × 100
Ask?$1.98 × 100
Spread?$0.62
Midpoint?$1.67
Valuation & Ratios
Market Cap?25.6M
Shares Out?15.9M
Float?15.8M
Float %?99.8%
P/E Ratio?N/A
P/B Ratio?3.70
EPS?-$0.71
Dividend?0.00%
Ex-Dividend?N/A

Shares of Allarity Therapeutics, Inc. Common Stock (ALLR) are trading at $1.61. ALLR shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, ALLR trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
8
Market Cap
25.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.allarity.com
Listed
2021-12-21
Address
24 SCHOOL ST., 2ND FLOOR
BOSTON, MA 02108
Phone: 401-426-4664
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
85
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.05Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.88%Low
Short Interest?296.9K
Days to Cover?1.0
Free Float15.8M
Avg Daily Volume287.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.88Weak
Quick Ratio?0.88Weak
Cash Ratio?0.71Adequate
Debt/Equity?3.11High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
47
3.70FAIR▾
P/S?
Peers
100
S&P
3
74.25HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
79.13HIGH▾
Returns & Efficiency
ROE?
S&P
3
-162.6%WEAK▾
ROA?
S&P
3
-32.2%WEAK▾
Cash Flow & Enterprise
FCF?$-16699000
Enterprise Value?$27.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist